XML 24 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Income Taxes

(5) Income Taxes

 

Since inception, the Company has incurred losses from operations and as a result has not recorded income tax expense. Benefits related to net operating loss carry-forwards and deferred items have been fully reserved since it is not more likely than not that the Company will achieve profitable operations. For the year ended December 31, 2018, the difference between the total income taxes at the federal statutory rate and the fact that there was no tax expense is attributable to both the federal rate reduction that was enacted as a part of the Act on December 22, 2017 as well as the change in the valuation allowance due to the net operating loss for the current year. The difference between the total income taxes at the federal statutory rate for each of the years ended December 31, 2018 and 2017 and the fact that no income tax benefit was recorded in each of these years is attributable to the change in the valuation allowance recorded in each year.

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets at December 31, 2018 and 2017 are presented below and reflect the new federal statutory rate enacted in 2017. The 2018 and2017 deferred tax amounts were adjusted for the effects of the new federal statutory rates.

 

    2018     2017  
Deferred tax assets:                
Depreciation   $ 87,000     $ 89,000  
Allowance for bad debts     234,000       225,000  
Net operating loss carry-forwards     15,528,000       15,575,000  
Stock option expense     257,000       257,000  
Research and other credits     1,161,000       1,266,000  
Other temporary differences     15,000       15,000  
Total gross deferred tax assets     17,284,000       17,427,000  
Less valuation allowance     (17,284,000 )     (17,427,000 )
    $ -     $ -  

 

The reconciliation of the income tax expense (benefit) computed at the Federal statutory tax rates to income tax expense (benefit) is as follows:

 

    2018     2017     2016  
Income Tax Provision at Federal Statutory Rate   $ (564,100 )   $ (844,900 )   $ (1,483,400 )
Permanent Differences     73,000       27,800       23,600  
Credits     (5,000 )     (50,000 )     (50,000 )
Other     640,000       655,400       245,100  
2017 Tax Reform Act     -       10,563,000       -  
Valuation Allowance     (143,900 )     (10,351,300 )     1,264,700  
Total Income Tax Provision   $ -     $ -     $ -  

 

In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon future taxable income during the period in which those temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon its historical operating losses, utilization of deferred tax assets cannot currently be determined. Accordingly, the Company has recorded a full valuation allowance against the deferred tax assets due to the uncertainty regarding the future utilization of the deferred tax assets for all periods presented.

 

At December 31, 2018, the Company had a net operating loss carry-forward for federal income tax purposes of approximately $72,562,000, of which a total of $70,180,000 will expire in varying amounts from 2019 through 2037. Research and other credit carry-forwards of approximately $1,161,000 are available to the Company to reduce income taxes payable in future years principally through 2038. The Company’s ability to utilize its net operating loss carryforwards and its current year tax credits in future periods could be subject to the 382 limitation. The Company will need to complete an analysis to determine whether its net operating losses are subject to the 382 limitation.